期刊文献+

国际药品价格管制方式及效果研究的系统综述 被引量:14

The international regulation methods of pharmaceutical pricing and their impacts: A systematic review
下载PDF
导出
摘要 目的:分析国际药品价格管制方式及效果。方法:采用系统综述的方法归纳不同国家药品价格管制方式、对象、过程及效果。结果:共纳入来自36个国家的130篇文献,其中包括定价管制政策文献97篇,评价定价管制影响文献33篇,且多为评价参考定价效果研究。大多国家主要对报销药品价格进行控制;国家价格比较和参考定价是两种最主要的政府定价方式;药品加成采用递减加成体系;现有证据表明参考定价对于降低药品价格、节省药品开支和对其他卫生服务的影响效果较好。建议:以药物经济学评价为基础,通过参考定价对药品报销价进行有效管制,通过协商谈判、递减加成和完善医保支付方式来控制药品费用不合理增长。 Objective: To analyze the measures and their impacts of different regulation methods in terms of pharmaceutical pricing.Methods: A systematic review is used to summarize different regulation methods of drug pricing,objects,implementation process and to evaluate the impacts of these regulations on pharmaceutical's utilization and production.Results: 130 studies covering 36 countries were included.Many studies(97 articles) aim to describe drug pricing strategies,while few studies(33 articles) are to evaluate the impacts of strategies,most of which aim to evaluate the effectiveness of reference price.Many countries only control the reimbursement price of the drug.International price comparison and internal price referencing are two main regulation methods.A regressive mark up system is often used.The existing evidences indicate that the reference price system could decrease the drug price,save the drug cost,and better the utilization of other healthcare.Recommendations: The effective regulation of drug price is to use the reference price to regulate the reimbursement price of the drugs,based on the pharmacoeconomics evaluation,to control the irrational drug cost by negotiating price,regressive mark-up and perfecting the third party payment method.
出处 《中国卫生政策研究》 2011年第7期17-24,共8页 Chinese Journal of Health Policy
基金 中国卫生政策支持项目(HPSP)知识管理领域(20080185) 2010年度教育部人文社会科学研究一般项目(9210003)
关键词 药品定价 参考定价 管制 效果 系统综述 Pharmaceutical pricing Reference pricing Regulation Impact Systematic review
  • 相关文献

参考文献18

  • 1Puig J. The Impact of Generic Reference Pricing Interven- tions in the Statin Market [ J ]. Health Policy, 2007, 84 (1) : 14-29.
  • 2赵延奎,郭洪伟,张功法,卡宜,王鸿勇.意大利药品费用控制政策的长期效果——最低参考价格政策实施状况[J].国外医学(卫生经济分册),2003,20(2):61-70. 被引量:3
  • 3Atella V. Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum refer- ence price[J]. Health Policy, 2000, 50(3) : 197-218.
  • 4Grootendorst P V, Marshall J K, Holbrook A M, et al. The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugs [ J ]. Health services research, 2005, 40(5 Pt 1 ) : 1297-1317.
  • 5Schneeweiss S. Reference drug programs: effectiveness and policy implications [ J ]. Health Policy, 2007, 81 ( 1 ) : 17-28.
  • 6Nilsson J L G, Melander A. Use of generic drugs and effects of the reference price system in Sweden [ J ]. Drug Informa-tion Journal, 2000, 34(4) : 1195-1200.
  • 7Woolcott J M. Lowering Generic Drug Prices: Less Regula- tion Equals More Competition[ J]. Medical Care, 2003, 41 (1) : 135-141.
  • 8Grootendorst P, Stewart D. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expendi- tures in British Columbia[ J]. Health Economics, 2006, 15 (7) : 735-42.
  • 9Meng Q Y, Cheng G, Silver L, et al. The impact of China' s retail drug price control policy on hospital expenditures: A case study in two Shandong hospitals [ J ]. Health Policy and Planning, 2005, 20(3): 185-196.
  • 10Brekke K R, Grasdal A L, Holmas T H. Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation? [ R]. CESIFO working paper, 2007.

共引文献2

同被引文献135

引证文献14

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部